Therapeutic Efficacy of Phytosterols on Metabolic Syndrome

NCT02969720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2020-03-17

No results posted yet for this study

Summary

The objective is to evaluate therapeutic efficacy of 2 grams nano-phytosterols daily supplemention on diagnosis criteria of metabolic syndrome.

Conditions

  • Metabolic Syndrome x

Interventions

DIETARY_SUPPLEMENT

Phytosterols

Oral daily consumption of 2 grams of phytosterols (8 ml) per 180 days.

DIETARY_SUPPLEMENT

Titanium Dioxide

Oral daily consumption of Titanium Dioxide (8 ml) per 180 days.

Sponsors & Collaborators

  • Universidad de los Andes, Chile

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-11-27
Completion
2018-11-27

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969720 on ClinicalTrials.gov